BT
GILD icon

Banque Transatlantique’s Gilead Sciences GILD Stock Holding History

Banque Transatlantique’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Sell
4,060
-56
-1% -$7.38K 0.01% 230
2026
Q1 		$574K Buy
+4,116
New +$576K 0.01% 182

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banque Transatlantique's GILD Position: Q2 2026 in Review

Banque Transatlantique reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $7.38K and leaving 4,060 shares worth $513K. The position accounts for 0.01% of the portfolio, ranked #230.

Banque Transatlantique first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $574K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Banque Transatlantique held 4,060 shares of Gilead Sciences worth $513K as of Q2 2026.
  • Banque Transatlantique sold 56 Gilead Sciences shares in Q2 2026, an estimated $7.38K.
  • Gilead Sciences made up 0.01% of Banque Transatlantique's portfolio in Q2 2026, its #230 holding.
  • Banque Transatlantique first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Banque Transatlantique's Gilead Sciences position peaked at $574K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.